Linda Boyle: FDA's Dr. Vinay Prasad, Big Pharma, politics, and the price of medical integrity
By LINDA BOYLE After just three months, Dr. Vinay Prasad stepped down as the head of Food and Drug Administration (FDA) Center for Biologics Evaluation and Research (CBER). CBER is…
